|
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
For
the quarterly period ended June 29, 2008
|
||
|
OR
|
||
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
|
Delaware
|
94-3008969
|
|
|
(State
or Other Jurisdiction of
|
(I.R.S.
Employer
|
|
|
Incorporation
or Organization)
|
Identification
No.)
|
|
Large
Accelerated Filer x
|
Accelerated
Filer ¨
|
Non-accelerated
filer ¨
(Do
not check if a smaller reporting company)
|
Smaller
reporting company ¨
|
|
Page
|
|||
|
3
|
|||
|
Item 1.
|
3
|
||
|
3
|
|||
|
4
|
|||
|
5
|
|||
|
6
|
|||
|
Item 2.
|
32
|
||
|
Item 3.
|
48
|
||
|
Item 4.
|
49
|
||
|
50
|
|||
|
Item 1.
|
50
|
||
|
Item 1A.
|
50
|
||
|
Item 4.
|
84
|
||
|
Item 6.
|
85
|
||
|
86
|
|||
|
87
|
|||
|
Item 1.
|
Financial
Statements
|
|
June
29,
2008
|
December 30,
2007
|
|||||||
|
Assets
|
||||||||
|
Current
assets:
|
||||||||
|
Cash and cash
equivalents
|
$
|
189,542
|
$
|
285,214
|
||||
|
Restricted cash,
current portion
|
38,322
|
—
|
||||||
|
Short-term
investments
|
37,233
|
105,453
|
||||||
|
Accounts
receivable, net
|
249,459
|
138,250
|
||||||
|
Costs and estimated
earnings in excess of billings
|
50,784
|
39,136
|
||||||
|
Inventories
|
200,268
|
140,504
|
||||||
|
Deferred project
costs
|
23,067
|
8,316
|
||||||
|
Advances to
suppliers, current portion
|
62,078
|
52,277
|
||||||
|
Prepaid expenses
and other current assets
|
61,044
|
33,110
|
||||||
|
Total
current assets
|
911,797
|
802,260
|
||||||
|
Restricted
cash, net of current portion
|
45,516
|
67,887
|
||||||
|
Long-term
investments
|
25,086
|
29,050
|
||||||
|
Property,
plant and equipment, net
|
451,969
|
377,994
|
||||||
|
Goodwill
|
195,930
|
184,684
|
||||||
|
Intangible
assets, net
|
45,623
|
50,946
|
||||||
|
Advances
to suppliers, net of current portion
|
96,400
|
108,943
|
||||||
|
Other
long-term assets
|
55,642
|
31,974
|
||||||
|
Total
assets
|
$
|
1,827,963
|
$
|
1,653,738
|
||||
|
Liabilities
and Stockholders’ Equity
|
||||||||
|
Current
liabilities:
|
||||||||
|
Accounts
payable
|
$
|
187,847
|
$
|
119,869
|
||||
|
Accounts payable to
Cypress
|
5,409
|
4,854
|
||||||
|
Accrued
liabilities
|
101,989
|
79,434
|
||||||
|
Billings in excess
of costs and estimated earnings
|
33,074
|
69,900
|
||||||
|
Customer advances,
current portion
|
15,340
|
9,250
|
||||||
|
Convertible
debt
|
200,000
|
425,000
|
||||||
|
Total
current liabilities
|
543,659
|
708,307
|
||||||
|
Convertible
debt
|
225,000
|
—
|
||||||
|
Deferred
tax liability
|
9,285
|
6,213
|
||||||
|
Customer
advances, net of current portion
|
59,665
|
60,153
|
||||||
|
Other
long-term
liabilities
|
22,176
|
14,975
|
||||||
|
Total
liabilities
|
859,785
|
789,648
|
||||||
|
Commitments
and Contingencies (Note 8)
|
||||||||
|
Stockholders’
Equity:
|
||||||||
|
Preferred stock,
$0.001 par value, 10,042,490 shares authorized; none issued and
outstanding
|
—
|
—
|
||||||
|
Common stock,
$0.001 par value, 375,000,000 shares authorized: 85,533,004 and 84,803,006
shares issued; 85,365,521 and 84,710,244 shares outstanding, at June 29,
2008 and December 30, 2007, respectively
|
85
|
85
|
||||||
|
Additional paid-in
capital
|
935,028
|
883,033
|
||||||
|
Accumulated other
comprehensive income
|
20,684
|
5,762
|
||||||
|
Accumulated
earnings (deficit)
|
18,550
|
(22,815
|
)
|
|||||
|
974,347
|
866,065
|
|||||||
|
Less: shares of
common stock held in treasury, at cost; 167,483 and 112,762 shares at June
29, 2008 and December 30, 2007, respectively
|
(6,169
|
)
|
(1,975
|
)
|
||||
|
Total
stockholders’ equity
|
968,178
|
864,090
|
||||||
|
Total
liabilities and stockholders’ equity
|
$
|
1,827,963
|
$
|
1,653,738
|
||||
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
|
June
29,
2008
|
July 1,
2007
|
June
29,
2008
|
July 1,
2007
|
|||||||||||||
|
Revenue:
|
||||||||||||||||
|
Systems
|
$
|
270,593
|
$
|
104,037
|
$
|
449,444
|
$
|
182,532
|
||||||||
|
Components
|
112,158
|
69,729
|
207,008
|
133,581
|
||||||||||||
|
Total
revenue
|
382,751
|
173,766
|
656,452
|
316,113
|
||||||||||||
|
Costs
and expenses:
|
||||||||||||||||
|
Cost of systems
revenue
|
209,137
|
91,518
|
352,350
|
153,984
|
||||||||||||
|
Cost of components
revenue
|
80,584
|
52,456
|
157,752
|
99,912
|
||||||||||||
|
Research and
development
|
4,813
|
2,821
|
9,455
|
5,757
|
||||||||||||
|
Sales, general and
administrative
|
43,208
|
26,109
|
77,066
|
48,480
|
||||||||||||
|
Purchased
in-process research and development
|
—
|
—
|
—
|
9,575
|
||||||||||||
|
Impairment of
acquisition-related intangibles
|
—
|
14,068
|
—
|
14,068
|
||||||||||||
|
Total
costs and expenses
|
337,742
|
186,972
|
596,623
|
331,776
|
||||||||||||
|
Operating income
(loss)
|
45,009
|
(13,206
|
)
|
59,829
|
(15,663
|
)
|
||||||||||
|
Other
income (expense):
|
||||||||||||||||
|
Interest
income
|
2,289
|
2,196
|
6,436
|
4,180
|
||||||||||||
|
Interest
expense
|
(1,411
|
)
|
(1,085
|
)
|
(2,875
|
)
|
(2,204
|
)
|
||||||||
|
Other,
net
|
(2,240
|
)
|
(517
|
)
|
(1,953
|
)
|
(243
|
)
|
||||||||
|
Other
income (expense), net
|
(1,362
|
)
|
594
|
1,608
|
1,733
|
|||||||||||
|
Income
(loss) before income taxes
|
43,647
|
(12,612
|
)
|
61,437
|
(13,930
|
)
|
||||||||||
|
Income tax
provision (benefit)
|
15,039
|
(7,267
|
)
|
20,072
|
(9,825
|
)
|
||||||||||
|
Net
income (loss)
|
$
|
28,608
|
$
|
(5,345
|
)
|
$
|
41,365
|
$
|
(4,105
|
)
|
||||||
|
Net
income (loss) per share:
|
||||||||||||||||
|
Basic
|
$
|
0.36
|
$
|
(0.07
|
)
|
$
|
0.52
|
$
|
(0.06
|
)
|
||||||
|
Diluted
|
$
|
0.34
|
$
|
(0.07
|
)
|
$
|
0.49
|
$
|
(0.06
|
)
|
||||||
|
Weighted-average
shares:
|
||||||||||||||||
|
Basic
|
79,412
|
75,123
|
79,188
|
74,428
|
||||||||||||
|
Diluted
|
84,036
|
75,123
|
83,848
|
74,428
|
||||||||||||
|
Six
Months Ended
|
||||||||
|
June
29,
2008
|
July
1,
2007
Note
1
|
|||||||
|
Cash
flows from operating activities:
|
||||||||
|
Net income
(loss)
|
$
|
41,365
|
$
|
(4,105
|
)
|
|||
|
Adjustments to reconcile net
income (loss) to net cash used in operating
activities:
|
||||||||
|
Depreciation
|
21,971
|
11,486
|
||||||
|
Impairment of
long-lived assets
|
5,489
|
—
|
||||||
|
Amortization of
intangible assets
|
8,351
|
14,551
|
||||||
|
Impairment of
acquisition-related intangibles
|
—
|
14,068
|
||||||
|
Amortization of debt
issuance costs
|
972
|
479
|
||||||
|
Stock-based
compensation
|
33,115
|
23,833
|
||||||
|
Purchased in-process
research and development
|
—
|
9,575
|
||||||
|
Share in net income
of joint venture
|
(1,874
|
)
|
—
|
|||||
|
Excess tax benefits
from stock-based award activity
|
(14,639
|
)
|
—
|
|||||
|
Deferred income taxes
and other tax liabilities
|
20,734
|
(10,568
|
)
|
|||||
|
Changes in operating
assets and liabilities, net of effect of
acquisitions:
|
||||||||
|
Accounts
receivable
|
(103,132
|
)
|
(215
|
)
|
||||
|
Costs and estimated
earnings in excess of billings
|
(10,144
|
)
|
(14,323
|
)
|
||||
|
Inventories
|
(53,048
|
)
|
(49,438
|
)
|
||||
|
Prepaid expenses and other
assets
|
(25,032
|
)
|
(3,893
|
)
|
||||
|
Deferred project
costs
|
(14,751
|
)
|
990
|
|||||
|
Advances to
suppliers
|
3,641
|
(15,586
|
)
|
|||||
|
Accounts payable and other
accrued liabilities
|
81,811
|
17,910
|
||||||
|
Accounts payable to
Cypress
|
555
|
2,993
|
||||||
|
Billings in excess of costs
and estimated earnings
|
(38,886
|
)
|
11,503
|
|||||
|
Customer
advances
|
4,130
|
(10,163
|
)
|
|||||
|
Net
cash used in operating activities
|
(39,372
|
)
|
(903
|
)
|
||||
|
Cash
flows from investing activities:
|
||||||||
|
Decrease (increase) in
restricted cash
|
(15,951
|
)
|
4,711
|
|||||
|
Purchases of property, plant
and equipment
|
(95,078
|
)
|
(107,585
|
)
|
||||
|
Purchases of
available-for-sale securities
|
(50,970
|
)
|
(25,555
|
)
|
||||
|
Proceeds from sales or
maturities of available-for-sale securities
|
121,921
|
16,496
|
||||||
|
Cash paid for acquisition,
net of cash acquired
|
(13,484
|
)
|
(98,645)
|
|||||
|
Cash paid for investments in
joint ventures and other private companies
|
(22,625
|
)
|
—
|
|||||
|
Net
cash used in investing activities
|
(76,187
|
)
|
(210,578
|
)
|
||||
|
Cash
flows from financing activities:
|
||||||||
|
Proceeds from exercises of
stock options
|
2,335
|
4,969
|
||||||
|
Excess tax benefits from
stock-based award activity
|
14,639
|
—
|
||||||
|
Purchases of stock for tax
withholding obligations on vested restricted stock
|
(4,194
|
)
|
—
|
|||||
|
Proceeds from issuance of
convertible debt
|
—
|
200,000
|
||||||
|
Convertible debt issuance
costs
|
—
|
(6,030
|
)
|
|||||
|
Principal payments on line
of credit and notes payable
|
—
|
(3,563
|
)
|
|||||
|
Net
cash provided by financing activities
|
12,780
|
195,376
|
||||||
|
Effect
of exchange rate changes on cash and cash
equivalents
|
7,107
|
861
|
||||||
|
Net
decrease in cash and cash equivalents
|
(95,672
|
)
|
(15,244
|
)
|
||||
|
Cash
and cash equivalents at beginning of period
|
285,214
|
165,596
|
||||||
|
Cash
and cash equivalents at end of period
|
$
|
189,542
|
$
|
150,352
|
||||
|
Non-cash
transactions:
|
||||||||
|
Additions to
property, plant and equipment acquired under accounts payable and other
accrued liabilities
|
$
|
3,838
|
$
|
3,741
|
||||
|
Change in goodwill
relating to adjustments to acquired net assets
|
231
|
1,689
|
||||||
|
Issuance of common
stock for purchase acquisition
|
—
|
111,266
|
||||||
|
Stock options
assumed in relation to acquisition
|
—
|
21,280
|
||||||
|
(In
thousands)
|
Components
Business
Segment
|
Systems
Business
Segment
|
Total
|
|||||||||
|
As
of December 30, 2007
|
$
|
2,883
|
$
|
181,801
|
$
|
184,684
|
||||||
|
Goodwill
acquired
|
10,284
|
—
|
10,284
|
|||||||||
|
Adjustments
|
962
|
—
|
962
|
|||||||||
|
As
of June 29, 2008
|
$
|
14,129
|
$
|
181,801
|
$
|
195,930
|
||||||
|
(In
thousands)
|
Gross
|
Accumulated
Amortization
|
Net
|
|||||||||
|
As
of June 29, 2008
|
||||||||||||
|
Patents and purchased
technology
|
$
|
51,398
|
$
|
(25,976
|
)
|
$
|
25,422
|
|||||
|
Tradenames
|
2,215
|
(1,244
|
)
|
971
|
||||||||
|
Backlog
|
11,787
|
(11,787
|
)
|
—
|
||||||||
|
Customer relationships and
other
|
25,612
|
(6,382
|
)
|
19,230
|
||||||||
|
$
|
91,012
|
$
|
(45,389
|
)
|
$
|
45,623
|
||||||
|
As
of December 30, 2007
|
||||||||||||
|
Patents and purchased
technology
|
$
|
51,398
|
$
|
(20,630
|
)
|
$
|
30,768
|
|||||
|
Tradenames
|
1,603
|
(808
|
)
|
795
|
||||||||
|
Backlog
|
11,787
|
(11,460
|
)
|
327
|
||||||||
|
Customer relationships and
other
|
23,193
|
(4,137
|
)
|
19,056
|
||||||||
|
$
|
87,981
|
$
|
(37,035
|
)
|
$
|
50,946
|
||||||
|
2008
(remaining six months)
|
$
|
8,041
|
||
|
2009
|
15,461
|
|||
|
2010
|
13,948
|
|||
|
2011
|
4,152
|
|||
|
2012
|
3,916
|
|||
|
Thereafter
|
105
|
|||
|
$
|
45,623
|
|||
|
(In
thousands)
|
June
29,
2008
|
December 30,
2007
|
||||||
|
Costs
and estimated earnings in excess of billings on contracts in progress and
billings in excess of costs and estimated earnings on contracts in
progress consists of the following:
|
||||||||
|
Costs and estimated
earnings in excess of billings on contracts in
progress
|
$
|
50,784
|
$
|
39,136
|
||||
|
Billings in excess
of costs and estimated earnings on contracts in
progress
|
33,074
|
69,900
|
||||||
|
$
|
17,710
|
$
|
(30,764
|
)
|
||||
|
Contracts
in progress:
|
||||||||
|
Costs incurred to
date
|
$
|
824,289
|
$
|
481,340
|
||||
|
Estimated earnings
to date
|
269,201
|
145,643
|
||||||
|
Contract revenue
earned to date
|
1,093,490
|
626,983
|
||||||
|
Less: Billings to
date, including earned incentive rebates
|
(1,075,780
|
)
|
(657,747
|
)
|
||||
|
$
|
17,710
|
$
|
(30,764
|
)
|
||||
|
Inventories:
|
||||||||
|
Raw materials(1)
|
$
|
98,534
|
$
|
89,604
|
||||
|
Work-in-process
|
3,972
|
2,027
|
||||||
|
Finished
goods
|
97,762
|
48,873
|
||||||
|
$
|
200,268
|
$
|
140,504
|
|||||
|
(1) In addition to
polysilicon and other raw materials for solar cell manufacturing, raw
materials includes solar panels purchased from third-party vendors and
installation materials for systems projects.
|
||||||||
|
Prepaid
expenses and other current assets:
|
||||||||
|
VAT receivables,
current portion
|
$
|
25,308
|
$
|
7,266
|
||||
|
Deferred tax
assets, current portion
|
8,438
|
8,437
|
||||||
|
Other
receivables
|
16,458
|
9,946
|
||||||
|
Other prepaid
expenses
|
10,840
|
7,461
|
||||||
|
$
|
61,044
|
$
|
33,110
|
|||||
|
Property,
plant and equipment, net:
|
||||||||
|
Land and
buildings
|
$
|
8,923
|
$
|
7,482
|
||||
|
Manufacturing
equipment
|
237,457
|
194,963
|
||||||
|
Manufacturing
equipment held for sale(2)
|
768
|
—
|
||||||
|
Computer
equipment
|
14,676
|
12,399
|
||||||
|
Furniture and
fixtures
|
3,920
|
2,648
|
||||||
|
Leasehold
improvements
|
130,425
|
113,801
|
||||||
|
Construction-in-process
(manufacturing facility in the Philippines)
|
127,178
|
99,945
|
||||||
|
523,347
|
431,238
|
|||||||
|
Less: Accumulated
depreciation(3)
|
(71,378
|
)
|
(53,244
|
)
|
||||
|
$
|
451,969
|
$
|
377,994
|
|||||
|
(In
thousands)
|
June
29,
2008
|
December 30,
2007
|
||||||
|
(2) During the
three months ended March 30, 2008, certain manufacturing equipment
with a net book value of $4.1 million were replaced with new processes.
The Company determined that the expected realizable value for the resale
of such manufacturing equipment is $0.8 million, therefore, the Company
incurred an impairment charge of $3.3 million in the first quarter of
fiscal 2008.
|
||||||||
|
(3) Total depreciation
expense was $11.9 million and $22.0 million for the three and
six months ended June 29, 2008, respectively, and $5.9 million and
$11.5 million for the three and six months ended July 1, 2007,
respectively.
|
||||||||
|
Other
long-term assets:
|
||||||||
|
VAT receivable, net
of current portion
|
$
|
15,422
|
$
|
24,269
|
||||
|
Investments in
joint ventures
|
14,803
|
5,304
|
||||||
|
Note
receivable(4)
|
10,000
|
—
|
||||||
|
Other
|
15,417
|
2,401
|
||||||
|
$
|
55,642
|
$
|
31,974
|
|||||
|
(4) In June 2008, the
Company loaned $10.0 million to a third-party private company pursuant to
a three-year interest-bearing note receivable that is convertible into
equity at the Company’s option.
|
||||||||
|
Accrued
liabilities:
|
||||||||
|
VAT
payables
|
$
|
28,592
|
$
|
18,138
|
||||
|
Employee
compensation and employee benefits
|
14,858
|
15,338
|
||||||
|
Income taxes
payable
|
15,316
|
11,106
|
||||||
|
Warranty
reserves
|
13,393
|
10,502
|
||||||
|
Foreign exchange
derivative liability
|
11,261
|
8,920
|
||||||
|
Other
|
18,569
|
15,430
|
||||||
|
$
|
101,989
|
$
|
79,434
|
|||||
|
(In thousands)
|
Quoted
Prices in Active
Markets
for Identical
Instruments
(Level
1)
|
Significant
Other
Observable
Inputs
(Level
2)
|
Significant
Unobservable
Inputs
(Level
3)
|
Balance
as of
June
29, 2008
|
||||||||||||
|
Asset
|
||||||||||||||||
|
Money market
funds
|
$
|
160,108
|
$
|
—
|
$
|
—
|
$
|
160,108
|
||||||||
|
Corporate
securities
|
—
|
33,244
|
25,086
|
58,330
|
||||||||||||
|
Commercial
paper
|
—
|
23,989
|
—
|
23,989
|
||||||||||||
|
Total
available-for-sale securities
|
$
|
160,108
|
$
|
57,233
|
$
|
25,086
|
$ |
242,427
|
||||||||
|
(In thousands)
|
Auction
Rate Securities
|
|||
|
Balance
at December 31, 2007
|
$
|
—
|
||
|
Transfers from
Level 2 to Level 3
|
29,050
|
|||
|
Purchases of
auction rate securities
|
10,000
|
|||
|
Unrealized loss
included in other comprehensive income
|
(1,445
|
)
|
||
|
Balance
at March 30, 2008
|
37,605
|
|||
|
Sales of auction
rate securities
|
(13,000
|
)
|
||
|
Unrealized gain
included in other comprehensive income
|
481
|
|||
|
Balance
at June 29, 2008
|
$
|
25,086
|
||
|
As
of June 29, 2008
|
||||||||||||||||||||||||
|
Less
than 12 Months
|
12
Months or Greater
|
Total
|
||||||||||||||||||||||
|
(In thousands)
|
Fair
Value
|
Gross
Unrealized Losses
|
Fair
Value
|
Gross
Unrealized Losses
|
Fair
Value
|
Gross
Unrealized Losses
|
||||||||||||||||||
|
Corporate
securities
|
$
|
48,283
|
$
|
(1,054
|
)
|
$
|
—
|
$
|
—
|
$
|
48,283
|
$
|
(1,054
|
)
|
||||||||||
|
As
of December 30, 2007
|
||||||||||||||||||||||||
|
Less
than 12 Months
|
12
Months or Greater
|
Total
|
||||||||||||||||||||||
|
(In thousands)
|
Fair
Value
|
Gross
Unrealized Losses
|
Fair
Value
|
Gross Unrealized
Losses
|
Fair
Value
|
Gross
Unrealized Losses
|
||||||||||||||||||
|
Corporate
securities
|
$
|
25,536
|
$
|
(50
|
)
|
$
|
—
|
$
|
—
|
$
|
25,536
|
$
|
(50
|
)
|
||||||||||
|
Commercial
paper
|
24,002
|
(2
|
)
|
—
|
—
|
24,002
|
(2
|
)
|
||||||||||||||||
|
$
|
49,538
|
$
|
(52
|
)
|
$
|
—
|
$
|
—
|
$
|
49,538
|
$
|
(52
|
)
|
|||||||||||
|
(In thousands)
|
June
29,
2008
|
December 30,
2007
|
||||||
|
Included
in:
|
||||||||
|
Cash
equivalents
|
$
|
96,270
|
$
|
249,582
|
||||
|
Short-term restricted
cash(1)
|
38,322
|
—
|
||||||
|
Short-term
investments
|
37,233
|
105,453
|
||||||
|
Long-term restricted
cash(1)
|
45,516
|
67,887
|
||||||
|
Long-term
investments
|
25,086
|
29,050
|
||||||
|
$
|
242,427
|
$
|
451,972
|
|||||
|
Contractual
maturities:
|
||||||||
|
Due in less than one
year
|
$
|
171,826
|
$
|
396,228
|
||||
|
Due from one to two years
(2)
|
2,382
|
4,994
|
||||||
|
Due from two to 30
years
|
68,219
|
50,750
|
||||||
|
$
|
242,427
|
$
|
451,972
|
|||||
|
(1)
|
The
Company provided security in the form of cash collateralized bank standby
letters of credit for advance payments received from
customers.
|
|
(2)
|
The
Company classifies all available-for-sale securities that are intended to
be available for use in current operations as short-term
investments.
|
|
2008
(remaining six months)
|
$
|
56,040
|
||
|
2009
|
78,006
|
|||
|
2010
|
59,642
|
|||
|
2011
|
19,792
|
|||
|
$
|
213,480
|
|||
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
|
(In
thousands)
|
June
29,
2008
|
July
1,
2007
|
June
29,
2008
|
July 1,
2007
|
||||||||||||
|
Employee
stock options
|
$
|
1,014
|
$
|
4,847
|
$
|
2,201
|
$
|
9,593
|
||||||||
|
Restricted
stock
|
10,229
|
3,266
|
18,130
|
4,520
|
||||||||||||
|
Shares
and options released from re-vesting restrictions
|
7,627
|
5,306
|
13,633
|
10,028
|
||||||||||||
|
Change
in stock-based compensation capitalized in inventory
|
(263
|
)
|
(189
|
)
|
(849
|
)
|
(308
|
)
|
||||||||
|
Total stock-based
compensation expense
|
$
|
18,607
|
$
|
13,230
|
$
|
33,115
|
$
|
23,833
|
||||||||
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||||||
|
(In
thousands)
|
June
29,
2008
|
July
1,
2007
|
June
29,
2008
|
July 1,
2007
|
||||||||||||
|
Cost
of systems revenue
|
$
|
2,239
|
$
|
2,189
|
$
|
4,750
|
$
|
4,186
|
||||||||
|
Cost
of components revenue
|
2,890
|
1,009
|
4,093
|
1,262
|
||||||||||||
|
Research
and development
|
972
|
348
|
1,783
|
849
|
||||||||||||
|
Sales,
general and administrative
|
12,506
|
9,684
|
22,489
|
17,536
|
||||||||||||
|
Total stock-based
compensation expense before income taxes
|
18,607
|
13,230
|
33,115
|
23,833
|
||||||||||||
|
Tax
effect on stock-based compensation expense
|
—
|
—
|
—
|
—
|
||||||||||||
|
Total stock-based
compensation expense after income taxes
|
$
|
18,607
|
$
|
13,230
|
$
|
33,115
|
$
|
23,833
|
||||||||
|
(In
thousands, except years)
|
As
of
June
29,
2008
|
Weighted-Average
Amortization Period
(in
years)
|
||||||
|
Stock
options
|
$
|
10,365
|
2.7
|
|||||
|
Restricted
stock
|
103,227
|
3.0
|
||||||
|
Shares
subject to re-vesting restrictions
|
15,423
|
0.5
|
||||||
|
Total unrecognized
stock-based compensation cost
|
$
|
129,015
|
||||||
|
Three
Months Ended
|
Six
Months Ended
|
|||||||
|
July 1, 2007
|
July 1, 2007
|
|||||||
|
Stock
Option Plans:
|
||||||||
|
Expected
term
|
6.5 years
|
6.5 years
|
||||||
|
Risk-free interest
rate
|
4.56%
|
4.62%
|
||||||
|
Volatility
|
90%
|
70.3%
|
||||||
|
Dividend
yield
|
0%
|
0%
|
||||||
|
No
stock options were granted in the six months ended June 29,
2008.
|
||||||||
|
Shares
(in thousands)
|
Weighted-
Average
Exercise
Price Per Share
|
|||||||
|
Outstanding
as of December 30, 2007
|
3,701
|
$
|
5.44
|
|||||
|
Granted
|
—
|
—
|
||||||
|
Exercised
|
(703
|
)
|
3.32
|
|||||
|
Forfeited
|
(32
|
)
|
7.86
|
|||||
|
Outstanding
as of June 29, 2008
|
2,966
|
5.92
|
||||||
|
Exercisable
as of June 29, 2008
|
1,329
|
4.22
|
||||||
|
Stock
Options
|
Restricted
Stock Awards and Units
|
|||||||||||||||
|
Shares
(in thousands)
|
Weighted-
Average
Exercise Price
Per Share
|
Shares
(in thousands)
|
Weighted-
Average
Grant Date Fair
Value Per Share
|
|||||||||||||
|
Outstanding
as of December 30, 2007
|
2,454
|
$
|
6.29
|
1,174
|
$
|
68.74
|
||||||||||
|
Granted
|
—
|
—
|
579
|
79.48
|
||||||||||||
|
Vested(1)
|
(786
|
)
|
4.13
|
(195
|
)
|
56.33
|
||||||||||
|
Forfeited
|
(31
|
)
|
7.45
|
(30
|
)
|
79.70
|
||||||||||
|
Outstanding
as of June 29, 2008
|
1,637
|
7.30
|
1,528
|
78.58
|
||||||||||||
|
(1)
Restricted stock awards and units vested includes shares withheld on
behalf of employees to satisfy the minimum statutory tax withholding
requirements.
|
||||||||||||||||
|
Options
Outstanding
|
Options
Exercisable
|
||||||||||||||||
|
Range of Exercise Price
|
Shares
(in
thousands)
|
Weighted-
Average
Remaining
Contractual
Life
(in years)
|
Weighted-
Average
Exercise
Price per
Share
|
Aggregate
Intrinsic
Value
(in
thousands)
|
Shares
(in
thousands)
|
Weighted-
Average
Remaining
Contractual
Life
(in years)
|
Weighted-
Average
Exercise
Price per
Share
|
Aggregate
Intrinsic
Value
(in thousands)
|
|||||||||
|
$
|
0.04—
|
0.75
|
465
|
3.64
|
$
|
0.31
|
$
|
33,667
|
260
|
4.61
|
$
|
0.49
|
$
|
18,801
|
|||
|
0.88—
|
2.66
|
191
|
6.40
|
2.09
|
13,487
|
58
|
6.04
|
1.99
|
4,084
|
||||||||
|
3.30—
|
4.95
|
1,661
|
6.37
|
3.33
|
115,258
|
851
|
6.40
|
3.32
|
59,089
|
||||||||
|
7.00—
|
16.20
|
327
|
7.17
|
8.51
|
21,011
|
100
|
7.18
|
8.75
|
6,401
|
||||||||
|
17.00—
|
62.51
|
322
|
8.02
|
27.03
|
14,711
|
60
|
7.93
|
27.84
|
2,680
|
||||||||
|
2,966
|
$
|
198,134
|
1,329
|
$
|
91,055
|
||||||||||||
|
2008
(remaining six months)
|
$
|
2,547
|
||
|
2009
|
5,144
|
|||
|
2010
|
4,839
|
|||
|
2011
|
3,547
|
|||
|
2012
|
3,140
|
|||
|
Thereafter
|
24,651
|
|||
|
$
|
43,868
|
|
2008
(remaining six months)
|
$
|
302,461
|
||
|
2009
|
431,894
|
|||
|
2010
|
534,751
|
|||
|
2011
|
543,726
|
|||
|
2012
|
344,639
|
|||
|
Thereafter
|
1,532,215
|
|||
|
$
|
3,689,686
|